Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
sulindac aldose reductase small molecule Successful target TTD , drugbank , DGIDB Degenerative polyarthritis[MeSHID:D010003]
Acute onset pain[MeSHID:D059787]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
1.9 approved,investigational inhibitor
sulindac aldo-keto reductase family 1 member b10 small molecule NA drugbank Degenerative polyarthritis[MeSHID:D010003]
Acute onset pain[MeSHID:D059787]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved,investigational inhibitor
sulindac mitogen-activated protein kinase 3 small molecule NA drugbank Degenerative polyarthritis[MeSHID:D010003]
Acute onset pain[MeSHID:D059787]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved,investigational inhibitor
sulindac peroxisome proliferator-activated receptor delta small molecule NA drugbank Degenerative polyarthritis[MeSHID:D010003]
Acute onset pain[MeSHID:D059787]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved,investigational negative modulator
sulindac prostaglandin d2 receptor 2 small molecule NA drugbank Degenerative polyarthritis[MeSHID:D010003]
Acute onset pain[MeSHID:D059787]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved,investigational antagonist
sulindac prostaglandin g/h synthase 1 small molecule NA drugbank , DGIDB Degenerative polyarthritis[MeSHID:D010003]
Acute onset pain[MeSHID:D059787]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.48 approved,investigational inhibitor
sulindac prostaglandin g/h synthase 2 small molecule NA drugbank , DGIDB Degenerative polyarthritis[MeSHID:D010003]
Acute onset pain[MeSHID:D059787]
Tendinitis[MeSHID:D052256]
Ankylosing spondylitis[MeSHID:D013167]
Rheumatoid Arthritis[MeSHID:D001172]
Arthritis
Gouty[MeSHID:D015210]
Bursitis[MeSHID:D002062]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.36 approved,investigational inhibitor
click here to return to the previous page